Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist

Journal of Orthopaedic Research

Volumn 22, Issue 2, 2004, Pages 427-435

  Cohen, Steven B ^a   Gill, Sanjitpal S ^a   Baer, Geoffrey S ^a   Leo, Brian M ^a   Scheld, W M ^a   Diduch, David R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

A2A agonist; Adenosine analogue; Arthrosis; Joint infection; Septic

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2 RECEPTOR AGONIST; ANTIBIOTIC AGENT; CEFTRIAXONE; GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; CHONDROPATHY; CHONDROPROTECTION; CLEARANCE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; JOINT DESTRUCTION; JOINT EFFUSION; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYNOVITIS;

ANIMALS; ARTHRITIS, INFECTIOUS; CARTILAGE, ARTICULAR; CEFTRIAXONE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HINDLIMB; JOINTS; LEUKOCYTE COUNT; LEUKOCYTES; PROTEOGLYCANS; PURINES; RABBITS; RECEPTORS, ADENOSINE A2; STAPHYLOCOCCUS AUREUS; SYNOVIAL MEMBRANE;

EID: 0742266788     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orthres.2003.08.011     Document Type: Article

References (45)

1. Barnes C.R. Mandell G.L. Carper H.T. et al. Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation Biochem. Pharm. 50 1995 1851-1857
2. Bouma M.G. Jeunhomme T.M. Boyle D.L. et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors J. Immun. 158 1997 5400-5408
3. Boyer J. Daniel D. Akeson W.H. et al. Effect of salicylate therapy on cartilage destruction in experimental pyarthrosis Clin. Orthop. 126 1977 302-304
4. Cronstein B.N. Rosenstein E.D. Kramer S.B. et al. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils J. Immun. 135 1985 1366-1371
5. 2-) release by activated human neutrophils Clin. Immun. & Immunopath. 42 1987 76-85
6. Cronstein B.N. Levin R.I. Philips M. et al. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors J. Immun. 148 1992 2201-2206
7. de la H.J. Nathan C.F. Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces J. Immun. 143 1989 596-602
8. Eriksson E. Arthroscopic management of septic arthritis Knee Surg. Sports Traumatol. Arthrosc. 8 2000 261
9. Farndale R.W. Sayers C.A. Barrett A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures Connect. Tissue Res. 9 1982 247-248
10. Farndale R.W. Buttle D.J. Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue Biochem. Biophys. Acta 883 1986 173-177
11. Hogan C.J. Fang G.D. Scheld W.M. et al. Inhibiting the inflammatory response in joint sepsis Arthroscopy 17 2001 311-315
12. Jafari H.S. Saez-Llorens X. Paris M. et al. Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine Haemophilus arthritis J. Infect. Dis. 168 1993 1186-1193
13. Kim Y.J. Sah R.L. Doong J.Y. Grodzinsky A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258 Anal. Biochem. 174 1988 168-176
14. Klompmakers A.A. Hendriks T. A spectrophotometric microassay for sulfated glycosaminoglycans using a laser densitometer Analyt. Biochem. 153 1986 80-84
15. Krieg A.M. A possible cause of joint destruction in septic arthritis Arthritis. Res. 1 1999 3-4
16. Mader J.T. Mohan D. Calhoun J. A practical guide to the diagnosis and management of bone and joint infections Drugs 54 1997 253-264 Review
17. Mankin H.J. Dorfman H. Lippiello L. Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data J. Bone Joint Surg. (Am) 53 1971 523-537
18. Martini C. Di Sacco S. Tacchi P. et al. A2 adenosine receptors in neutrophils from healthy volunteers and patients with rheumatic disease Adv. Exp. Med. Bio. A 309 1991 459-462
19. McCachren S.S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium Arthritis. Rheum. 34 1991 1085-1093
20. McDonnell J. Hoerrner L.A. Lark M.W. et al. Recombinant human interleukin-1 beta-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid Arthritis. Rheum. 35 1992 799-805
21. Murphy G. Docherty A.J. Hembry R.M. Reynolds J.J. Metalloproteinases and tissue damage Br. J. Rheum. 30S 1991 31
22. Nielson C.P. Vestal R.E. Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3′:5′-adenosine monophosphate, and intracellular calcium Br. J. Pharm. 97 1989 882-888
23. Nord K.D. Dore D.D. Deeney V.F. et al. Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1 J. Bone Joint Surg. (Am) 77 1995 258-265
24. Pettipher E.R. Henderson B. The relationship between cell-mediated immunity and cartilage degradation in antigen-induced arthritis in the rabbit Br. J. Exp. Pathol. 69 1988 113-122
25. Pioro M.H. Mandell B.F. Septic arthritis Rheum. Dis. Clin. N. Am. 23 1997 239-258
26. Richter J. Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils J. Leukocyte Biol. 51 1992 270-275
27. Sacks T. Moldow C.F. Craddock P.R. et al. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage J. Clin. Invest. 61 1978 1161-1167
28. Saez-Llorens X. Jafari H.S. Olsen K.D. et al. Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta J. Infect. Dis. 163 1991 1267-1272
29. Salmon J.E. Cronstein B.N. Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory J. Immun. 145 1990 2235-2240
30. Salter R.B. Bell R.S. Keeley F.W. The protective effect of continuous passive motion in living articular cartilage in acute septic arthritis: an experimental investigation in the rabbit Clin. Orthop, 159 1981 223-247
31. Schrier D.J. Imre K.M. The effects of adenosine agonists on human neutrophil function J. Immun. 137 1986 3284-3289
32. Schurman D.J. Mirra J. Ding A. Nagel D.A. Experimental E. coli arthritis in the rabbit. A model of infectious and post-infectious inflammatory synovitis J. Rheumatol. 4 1977 118-128
33. Schurman D.J. Kajiyama G. Nagel D.A. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics J. Bone Joint Surg. (Am) 62 1980 620-627
34. Skyhar M.J. Mubarak S.J. Arthroscopic treatment of septic knees in children J. Ped. Orthop. 7 1987 647-651
35. Smith R.L. Schurman D.J. Kajiyama G. et al. The effect of antibiotics on the destruction of cartilage in experimental infectious arthritis J. Bone Joint Surg. (Am) 69 1987 1063-1068
36. Smith R.L. Kajiyama G. Schurman D.J. Staphylococcal septic arthritis: Antibiotic and nonsteroidal anti-inflammatory drug treatment in a rabbit model J. Orthop. Res. 15 1997 919-926
37. Stutz G. Kuster M.S. Kleinstuck F. Gachter A. Arthroscopic management of septic arthritis: stages of infection and results Knee Surg. Sports Traumatol. Arthrosc. 8 2000 270-274
38. Sullivan G.W. Linden J. Hewlett E.L. et al. Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: Implication of a novel cyclic AMP-independent action on the cell surface J. Immun. 145 1990 1537-1544
39. Sullivan G.W. Carper H.T. Mandell G.L. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity Int. J. Immunopharm. 17 1995 793-803
40. Sullivan G.W. Luong L.S. Carper H.T. et al. Methylxanthines with adenosine alter TNF alpha-primed PMN activation Immunopharm. 31 1995 19-29
41. Sullivan G.W. Linden J. Buster B.L. Scheld W.M. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: Synergy with the type IV phosphodiesterase inhibitor, rolipram J. Infect. Dis. 180 1999 1550-1560
42. Sullivan GW, Fang G, Linden J, Scheld WM. A2a adenosine receptor activation improves survival in a murine model endotoxemia, in press
43. Tarkowski A. Wagner H. Arthritis and sepsis caused by Staphylococcus aureus: Can the tissue injury be reduced by modulating the host's immune system? Mol. Med. Today 4 1998 15-18
44. Thiery J.A. Arthroscopic drainage in septic arthritides of the knee: A multicenter study Arthroscopy 5 1989 65-69
45. Zhang Y. Fredholm B.B. Propentofylline enhancement of the actions of adenosine on neutrophil leukocytes Biochem. Pharm. 48 1994 2025-2032